Chemical Component Summary

Name4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE
SynonymsOXYPHENBUTAZONE
Identifiers(4S)-4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione
FormulaC19 H20 N2 O3
Molecular Weight324.37
TypeNON-POLYMER
Isomeric SMILESCCCC[C@H]1C(=O)N(N(C1=O)c2ccc(cc2)O)c3ccccc3
InChIInChI=1S/C19H20N2O3/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15/h4-8,10-13,17,22H,2-3,9H2,1H3/t17-/m0/s1
InChIKeyHFHZKZSRXITVMK-KRWDZBQOSA-N

Chemical Details

Formal Charge0
Atom Count44
Chiral Atom Count1
Bond Count46
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB03585 
NameOxyphenbutazone
Groups
  • approved
  • withdrawn
DescriptionOxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
Synonyms
  • Oxyphenbutazone
  • Oxyphenbutazone monohydrate
  • Oxifenbutazona
  • Oxiphenbutazone
  • Oxyphenbutazonum
Brand Names
  • Oxybutazone Tab 100mg
  • Oxyphenbutazone 100mg Tablets
Categories
  • Agents causing hyperkalemia
  • Agents that produce hypertension
  • Analgesics
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents
ATC-Code
  • M01AA03
  • M02AA04
  • S01BC02
CAS number129-20-4

Drug Targets

NameTarget SequencePharmacological ActionActions
Group IIE secretory phospholipase A2MKSPHVLVFLCLLVALVTGNLVQFGVMIEKMTGKSALQYNDYGCYCGIGG...unknown
Serum albuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknown
Solute carrier family 22 member 6MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem448033
ChEMBLCHEMBL1235001